|
KMID : 0606920170250030288
|
|
Biomolecules & Therapeutics
2017 Volume.25 No. 3 p.288 ~ p.295
|
|
|
Bosentan and Rifampin Interactions Modulate Influx Transporter and Cytochrome P450 Expression and Activities in Primary Human Hepatocytes
|
|
Han Kyoung-Moon
Ahn Sun-Young
Seo Hye-Won
Yun Jae-Suk
Cha Hye-Jin
Shin Ji-Soon
Kim Young-Hoon
Kim Hyung-Soo
Park Hye-Kyung
Lee Yong-Moon
|
|
|
Abstract
|
|
|
|
The incidence of polypharmacy-which can result in drug-drug interactions-has increased in recent years. Drug-metabolizing enzymes and drug transporters are important polypharmacy modulators. In this study, the effects of bosentan and rifampin on the expression and activities of organic anion-transporting peptide (OATP) and cytochrome P450 (CYP450) 2C9 and CYP3A4 were investigated in vitro. HEK293 cells and primary human hepatocytes overexpressing the target genes were treated with bosentan and various concentrations of rifampin, which decreased the uptake activities of OATP transporters in a dose-dependent manner. In primary human hepatocytes, CYP2C9 and CYP3A4 gene expression and activities decreased upon treatment with 20 μM bosentan+200 μM rifampin. Rifampin also reduced gene expression of OATP1B1, OATP1B3, and OATP2B1 transporter, and inhibited bosentan influx in human hepatocytes at increasing concentrations. These results confirm rifampin- and bosentan-induced interactions between OATP transporters and CYP450.
|
|
|
KEYWORD
|
|
|
Drug-drug interaction, CYP450, OATP transporters, Rifampin, Bosentan
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|